Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

作者: J. A. Sprowl , G. Ciarimboli , C. S. Lancaster , H. Giovinazzo , A. A. Gibson

DOI: 10.1073/PNAS.1305321110

关键词: Organic cation transport proteinsCytotoxicityAllodyniaOxaliplatinToxicityNervous systemNeurotoxicityPharmacologyNeurotoxicity SyndromeChemistry

摘要: Oxaliplatin is an integral component of colorectal cancer therapy, but its clinical use associated with a dose-limiting peripheral neurotoxicity. We found that the organic cation transporter 2 (OCT2) expressed on dorsal root ganglia cells within nervous system where oxaliplatin known to accumulate. Cellular uptake was increased by 16- 35-fold in overexpressing mouse Oct2 or human OCT2, and this process DNA platination oxaliplatin-induced cytotoxicity. Furthermore, genetic pharmacologic knockout protected mice from hypersensitivity cold mechanical-induced allodynia, which are established tests assess acute These findings provide rationale for development targeted approaches mitigate debilitating toxicity.

参考文章(29)
H Burger, A Zoumaro-Djayoon, AWM Boersma, J Helleman, EMJJ Berns, RHJ Mathijssen, WJ Loos, EAC Wiemer, Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2). British Journal of Pharmacology. ,vol. 159, pp. 898- 908 ,(2010) , 10.1111/J.1476-5381.2009.00569.X
I. Buß, G.V. Kalayda, P. Marques-Gallego, J. Reedijk, U. Jaehde, Influence of the hOCT2 inhibitor cimetidine on the cellular accumulation and cytotoxicity of oxaliplatin Int. Journal of Clinical Pharmacology and Therapeutics. ,vol. 47, pp. 51- 54 ,(2009) , 10.5414/CPP47051
Giuliano Ciarimboli, Dirk Deuster, Arne Knief, Michael Sperling, Michael Holtkamp, Bayram Edemir, Hermann Pavenstädt, Claudia Lanvers-Kaminsky, Antoinette am Zehnhoff-Dinnesen, Alfred H. Schinkel, Hermann Koepsell, Heribert Jürgens, Eberhard Schlatter, Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions The American Journal of Pathology. ,vol. 176, pp. 1169- 1180 ,(2010) , 10.2353/AJPATH.2010.090610
Susanna B. Park, Cindy S.-Y. Lin, Arun V. Krishnan, David Goldstein, Michael L. Friedlander, Matthew C. Kiernan, Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy Brain. ,vol. 132, pp. 2712- 2723 ,(2009) , 10.1093/BRAIN/AWP219
Susanna B. Park, Cindy S-Y. Lin, Arun V. Krishnan, David Goldstein, Michael L. Friedlander, Matthew C. Kiernan, Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0018469
Elizabeth S. McDonald, Kelli R. Randon, Andrew Knight, Anthony J. Windebank, Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiology of Disease. ,vol. 18, pp. 305- 313 ,(2005) , 10.1016/J.NBD.2004.09.013
Cynthia L Renn, Valentina A Carozzi, Peter Rhee, Danisha Gallop, Susan G Dorsey, Guido Cavaletti, Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice Molecular Pain. ,vol. 7, pp. 29- 29 ,(2011) , 10.1186/1744-8069-7-29
Stefano Cascinu, Vincenzo Catalano, Luigi Cordella, Roberto Labianca, Paolo Giordani, Anna Maria Baldelli, Giordano D. Beretta, Emilio Ubiali, Giuseppina Catalano, Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial Journal of Clinical Oncology. ,vol. 20, pp. 3478- 3483 ,(1995) , 10.1200/JCO.2002.07.061
Sarah R. McWhinney, Richard M. Goldberg, Howard L. McLeod, Platinum neurotoxicity pharmacogenetics Molecular Cancer Therapeutics. ,vol. 8, pp. 10- 16 ,(2009) , 10.1158/1535-7163.MCT-08-0840
Keiichiro Ishibashi, Norimichi Okada, Tatsuya Miyazaki, Motohiko Sano, Hideyuki Ishida, Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study International Journal of Clinical Oncology. ,vol. 15, pp. 82- 87 ,(2010) , 10.1007/S10147-009-0015-3